Epstein Files Full PDF

CLICK HERE
Technopedia Center
PMB University Brochure
Faculty of Engineering and Computer Science
S1 Informatics S1 Information Systems S1 Information Technology S1 Computer Engineering S1 Electrical Engineering S1 Civil Engineering

faculty of Economics and Business
S1 Management S1 Accountancy

Faculty of Letters and Educational Sciences
S1 English literature S1 English language education S1 Mathematics education S1 Sports Education
teknopedia

  • Registerasi
  • Brosur UTI
  • Kip Scholarship Information
  • Performance
Flag Counter
  1. World Encyclopedia
  2. SMAD9
SMAD9
From Wikipedia, the free encyclopedia
(Redirected from SMAD8)
Protein-coding gene in the species Homo sapiens
SMAD9
Identifiers
AliasesSMAD9, MADH6, MADH9, PPH2, SMAD8, SMAD8A, SMAD8B, SMAD8/9, SMAD family member 9
External IDsOMIM: 603295; MGI: 1859993; HomoloGene: 21198; GeneCards: SMAD9; OMA:SMAD9 - orthologs
Gene location (Human)
Chromosome 13 (human)
Chr.Chromosome 13 (human)[1]
Chromosome 13 (human)
Genomic location for SMAD9
Genomic location for SMAD9
Band13q13.3Start36,844,831 bp[1]
End36,920,765 bp[1]
Gene location (Mouse)
Chromosome 3 (mouse)
Chr.Chromosome 3 (mouse)[2]
Chromosome 3 (mouse)
Genomic location for SMAD9
Genomic location for SMAD9
Band3|3 CStart54,663,003 bp[2]
End54,708,678 bp[2]
RNA expression pattern
Bgee
HumanMouse (ortholog)
Top expressed in
  • corpus epididymis

  • caput epididymis

  • urethra

  • tail of epididymis

  • seminal vesicula

  • spinal ganglia

  • trigeminal ganglion

  • subthalamic nucleus

  • endometrium

  • superficial temporal artery
Top expressed in
  • female urethra

  • yolk sac

  • primary visual cortex

  • genital tubercle

  • cerebellar cortex

  • superior frontal gyrus

  • lumbar subsegment of spinal cord

  • amnion

  • chorion

  • dentate gyrus of hippocampal formation granule cell
More reference expression data
BioGPS
n/a
Gene ontology
Molecular function
  • DNA binding
  • DNA-binding transcription factor activity
  • metal ion binding
  • protein binding
  • DNA-binding transcription factor activity, RNA polymerase II-specific
Cellular component
  • SMAD protein complex
  • transcription regulator complex
  • intracellular anatomical structure
  • nucleoplasm
  • nucleus
  • cytoplasm
  • cytosol
Biological process
  • ureteric bud development
  • regulation of transcription, DNA-templated
  • SMAD protein signal transduction
  • cellular response to organic cyclic compound
  • hindbrain development
  • cellular response to BMP stimulus
  • BMP signaling pathway
  • transcription, DNA-templated
  • protein phosphorylation
  • cartilage development
  • bone development
  • transforming growth factor beta receptor signaling pathway
  • midbrain development
  • positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus
Sources:Amigo / QuickGO
Orthologs
SpeciesHumanMouse
Entrez

4093

55994

Ensembl

ENSG00000120693

ENSMUSG00000027796

UniProt

O15198

Q9JIW5

RefSeq (mRNA)

NM_001127217
NM_005905
NM_001378621

NM_019483

RefSeq (protein)

NP_001120689
NP_005896
NP_001365550

NP_062356

Location (UCSC)Chr 13: 36.84 – 36.92 MbChr 3: 54.66 – 54.71 Mb
PubMed search[3][4]
Wikidata
View/Edit HumanView/Edit Mouse

Mothers against decapentaplegic homolog 9 also known as SMAD9, SMAD8, and MADH6 is a protein that in humans is encoded by the SMAD9 gene.[5]

SMAD9, as its name describes, is a homolog of the Drosophila gene: "Mothers against decapentaplegic". It belongs to the SMAD family of proteins, which belong to the TGFβ superfamily of modulators. Like many other TGFβ family members, SMAD9 is involved in cell signalling. When a bone morphogenetic protein binds to a receptor (BMP type 1 receptor kinase) it causes SMAD9 to interact with SMAD anchor for receptor activation (SARA).The binding of ligands causes the phosphorylation of the SMAD9 protein and the dissociation from SARA and the association with SMAD4. It is subsequently transferred to the nucleus where it forms complexes with other proteins and acts as a transcription factor. SMAD9 is a receptor regulated SMAD (R-SMAD) and is activated by bone morphogenetic protein type 1 receptor kinase. There are two isoforms of the protein. Confusingly, it is also sometimes referred to as SMAD8 in the literature.

Nomenclature

[edit]

The SMAD proteins are homologs of both the drosophila protein, mothers against decapentaplegic (MAD) and the C. elegans protein SMA. The name is a combination of the two. During Drosophila research, it was found that a mutation in the gene, MAD, in the mother, repressed the gene, decapentaplegic, in the embryo. The phrase "Mothers against" was added since mothers often form organizations opposing various issues e.g. Mothers Against Drunk Driving or (MADD); and based on a tradition of such unusual naming within the gene research community.[6]

References

[edit]
  1. ^ a b c GRCh38: Ensembl release 89: ENSG00000120693 – Ensembl, May 2017
  2. ^ a b c GRCm38: Ensembl release 89: ENSMUSG00000027796 – Ensembl, May 2017
  3. ^ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  4. ^ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  5. ^ Watanabe TK, Suzuki M, Omori Y, Hishigaki H, Horie M, Kanemoto N, Fujiwara T, Nakamura Y, Takahashi E (June 1997). "Cloning and characterization of a novel member of the human Mad gene family (MADH6)". Genomics. 42 (3): 446–51. doi:10.1006/geno.1997.4753. PMID 9205116.
  6. ^ "Sonic Hedgehog, DICER, and the Problem With Naming Genes", Sep 26, 2014, Michael White. psmag.com
  • v
  • t
  • e
Cell signaling: TGFβ signaling pathway
TGF beta superfamily of ligands
Ligand of ACVR or TGFBR
  • TGF beta family
    • TGF-β1
    • TGF-β2
    • TGF-β3
  • Activin and inhibin
    • INHA
    • INHBA
    • INHBB
    • INHBC
  • Nodal
Ligand of BMPR
  • Bone morphogenetic proteins
    • BMP2
    • BMP3
    • BMP4
    • BMP5
    • BMP6
    • BMP7
    • BMP8a
    • BMP8b
    • BMP10
    • BMP15
  • Growth differentiation factors
    • GDF1
    • GDF2
    • GDF3
    • GDF5
    • GDF6
    • GDF7
    • Myostatin/GDF8
    • GDF9
    • GDF10
    • GDF11
    • GDF15
  • Anti-müllerian hormone
TGF beta receptors
(Activin, BMP, family)
TGFBR1:
  • Activin type 1 receptors
    • ACVR1
    • ACVR1B
    • ACVR1C
  • ACVRL1
  • BMPR1
    • BMPR1A
    • BMPR1B
TGFBR2:
  • Activin type 2 receptors
    • ACVR2A
    • ACVR2B
  • AMHR2
  • BMPR2
TGFBR3:
  • Betaglycan
Transducers/SMAD
  • R-SMAD (SMAD1
  • SMAD2
  • SMAD3
  • SMAD5
  • SMAD9)
  • I-SMAD (SMAD6
  • SMAD7)
  • SMAD4
Ligand inhibitors
  • Cerberus
  • Chordin
  • Decorin
  • Follistatin
  • Gremlin
  • Lefty
  • LTBP1
  • Noggin
  • PARN
  • THBS1
Coreceptors
  • BAMBI
  • Cripto
Other
  • SARA
  • v
  • t
  • e
Transcription factors and intracellular receptors
(1) Basic domains
(1.1) Basic leucine zipper (bZIP)
  • Activating transcription factor
    • AATF
    • 1
    • 2
    • 3
    • 4
    • 5
    • 6
    • 7
  • AP-1
    • c-Fos
    • FOSB
    • FOSL1
    • FOSL2
    • JDP2
    • c-Jun
    • JUNB
    • JunD
  • BACH
    • 1
    • 2
  • BATF
  • BLZF1
  • C/EBP
    • α
    • β
    • γ
    • δ
    • ε
    • ζ
  • CREB
    • 1
    • 3
    • L1
  • CREM
  • DBP
  • DDIT3
  • GABPA
  • GCN4
  • HLF
  • MAF
    • B
    • sMaf
      • F
      • G
      • K
  • NFE
    • 2
    • L1
    • L2
    • L3
  • NFIL3
  • NRL
  • NRF
    • 1
    • 2
    • 3
  • XBP1
(1.2) Basic helix-loop-helix (bHLH)
Group A
  • AS-C
    • ASCL1
    • ASCL2
  • ATOH1
  • HAND
    • 1
    • 2
  • MESP2
  • Myogenic regulatory factors
    • MyoD
    • Myogenin
    • MYF5
    • MYF6
  • NeuroD
    • 1
    • 2
  • Neurogenins
    • 1
    • 2
    • 3
  • OLIG
    • 1
    • 2
  • Paraxis
    • TCF15
    • Scleraxis
  • SLC
    • LYL1
    • TAL
      • 1
      • 2
  • Twist
Group B
  • FIGLA
  • Myc
    • c-Myc
    • l-Myc
    • n-Myc
  • MXD4
  • TCF4
Group C
bHLH-PAS
  • AhR
  • AHRR
  • ARNT
    • ARNTL
    • ARNTL2
  • CLOCK
  • HIF
    • 1A
    • EPAS1
    • 3A
  • NPAS
    • 1
    • 2
    • 3
  • PER
    • 1
    • 2
    • 3
    • Period
  • SIM
    • 1
    • 2
Group D
  • DEC
    • 1
    • 2
  • BHLHA9
  • Pho4
  • ID
    • 1
    • 2
    • 3
    • 4
Group E
  • HES
    • 1
    • 2
    • 3
    • 4
    • 5
    • 6
    • 7
  • HEY
    • 1
    • 2
    • L
Group F
bHLH-COE
  • EBF1
(1.3) bHLH-ZIP
  • AP-4
  • MAX
    • MXD1
    • MXD3
  • MITF
  • MNT
  • MLX
  • MLXIPL
  • MXI1
  • Myc
  • SREBP
    • 1
    • 2
  • USF1
(1.4) NF-1
  • NFI
    • A
    • B
    • C
    • X
  • SMAD
    • R-SMAD
      • 1
      • 2
      • 3
      • 5
      • 9
    • I-SMAD
      • 6
      • 7
    • 4)
(1.5) RF-X
  • RFX
    • 1
    • 2
    • 3
    • 4
    • 5
    • 6
    • ANK
(1.6) Basic helix-span-helix (bHSH)
  • AP-2
    • α
    • β
    • γ
    • δ
    • ε
(2) Zinc finger DNA-binding domains
(2.1) Nuclear receptor (Cys4)
subfamily 1
  • Thyroid hormone
    • α
    • β
  • CAR
  • FXR
  • LXR
    • α
    • β
  • PPAR
    • α
    • β/δ
    • γ
  • PXR
  • RAR
    • α
    • β
    • γ
  • ROR
    • α
    • β
    • γ
  • Rev-ErbA
    • α
    • β
  • VDR
subfamily 2
  • COUP-TF
    • (I
    • II
  • Ear-2
  • HNF4
    • α
    • γ
  • PNR
  • RXR
    • α
    • β
    • γ
  • Testicular receptor
    • 2
    • 4
  • TLX
subfamily 3
  • Steroid hormone
    • Androgen
    • Estrogen
      • α
      • β
    • Glucocorticoid
    • Mineralocorticoid
    • Progesterone
  • Estrogen related
    • α
    • β
    • γ
subfamily 4
  • NUR
    • NGFIB
    • NOR1
    • NURR1
subfamily 5
  • LRH-1
  • SF1
subfamily 6
  • GCNF
subfamily 0
  • DAX1
  • SHP
(2.2) Other Cys4
  • GATA
    • 1
    • 2
    • 3
    • 4
    • 5
    • 6
  • MTA
    • 1
    • 2
    • 3
  • TRPS1
(2.3) Cys2His2
  • General transcription factors
    • TFIIA
    • TFIIB
    • TFIID
    • TFIIE
      • 1
      • 2
    • TFIIF
    • 1
    • 2
      • TFIIH
      • 1
      • 2
      • 4
      • 2I
      • 3A
      • 3C1
      • 3C2
  • ATBF1
  • BCL
    • 6
    • 11A
    • 11B
  • CTCF
  • E4F1
  • EGR
    • 1
    • 2
    • 3
    • 4
  • ERV3
  • GFI1
  • GLI family
    • 1
    • 2
    • 3
    • REST
    • S1
    • S2
    • YY1
  • HIC
    • 1
    • 2
  • HIVEP
    • 1
    • 2
    • 3
  • IKZF
    • 1
    • 2
    • 3
  • ILF
    • 2
    • 3
  • Sp/KLF family
    • KLF
      • 1
      • 2
      • 3
      • 4
      • 5
      • 6
      • 7
      • 8
      • 9
      • 10
      • 11
      • 12
      • 13
      • 14
      • 15
      • 17
    • SP
      • 1
      • 2
      • 4
      • 7
      • 8
  • MTF1
  • MYT1
  • OSR1
  • PRDM9
  • SALL
    • 1
    • 2
    • 3
    • 4
  • TSHZ3
  • WT1
  • Zbtb7
    • 7A
    • 7B
  • ZBTB
    • 11
    • 16
    • 17
    • 20
    • 21
    • 32
    • 33
    • 40
  • zinc finger
    • 3
    • 7
    • 9
    • 10
    • 19
    • 22
    • 24
    • 33B
    • 34
    • 35
    • 41
    • 43
    • 44
    • 51
    • 74
    • 143
    • 146
    • 148
    • 165
    • 202
    • 217
    • 219
    • 238
    • 239
    • 259
    • 267
    • 268
    • 281
    • 300
    • 318
    • 330
    • 346
    • 350
    • 365
    • 366
    • 384
    • 423
    • 451
    • 452
    • 471
    • 593
    • 638
    • 644
    • 649
    • 655
    • 804A
(2.4) Cys6
  • HIVEP1
(2.5) Alternating composition
  • AIRE
  • DIDO1
  • GRLF1
  • ING
    • 1
    • 2
    • 4
  • JARID
    • 1A
    • 1B
    • 1C
    • 1D
    • 2
  • JMJD1B
(2.6) WRKY
  • WRKY
(3) Helix-turn-helix domains
(3.1) Homeodomain
Antennapedia
ANTP class
protoHOX
Hox-like
  • ParaHox
    • Gsx
      • 1
      • 2
    • Xlox
      • PDX1
    • Cdx
      • 1
      • 2
      • 4
  • extended Hox: Evx1
  • Evx2
  • MEOX1
  • MEOX2
  • Homeobox
    • A1
    • A2
    • A3
    • A4
    • A5
    • A7
    • A9
    • A10
    • A11
    • A13
    • B1
    • B2
    • B3
    • B4
    • B5
    • B6
    • B7
    • B8
    • B9
    • B13
    • C4
    • C5
    • C6
    • C8
    • C9
    • C10
    • C11
    • C12
    • C13
    • D1
    • D3
    • D4
    • D8
    • D9
    • D10
    • D11
    • D12
    • D13
  • GBX1
  • GBX2
  • MNX1
metaHOX
NK-like
  • BARHL1
  • BARHL2
  • BARX1
  • BARX2
  • BSX
  • DBX
    • 1
    • 2
  • DLX
    • 1
    • 2
    • 3
    • 4
    • 5
    • 6
  • EMX
    • 1
    • 2
  • EN
    • 1
    • 2
  • HHEX
  • HLX
  • LBX1
  • LBX2
  • MSX
    • 1
    • 2
  • NANOG
  • NKX
    • 2-1
    • 2-2
    • 2-3
    • 2-5
    • 3-1
    • 3-2
    • HMX1
    • HMX2
    • HMX3
    • 6-1
    • 6-2
  • NOTO
  • TLX1
  • TLX2
  • TLX3
  • VAX1
  • VAX2
other
  • ARX
  • CRX
  • CUTL1
  • FHL
    • 1
    • 2
    • 3
  • HESX1
  • HOPX
  • LMX
    • 1A
    • 1B
  • NOBOX
  • TALE
    • IRX
      • 1
      • 2
      • 3
      • 4
      • 5
      • 6
      • MKX
    • MEIS
      • 1
      • 2
    • PBX
      • 1
      • 2
      • 3
    • PKNOX
      • 1
      • 2
    • SIX
      • 1
      • 2
      • 3
      • 4
      • 5
  • PHF
    • 1
    • 3
    • 6
    • 8
    • 10
    • 16
    • 17
    • 20
    • 21A
  • POU domain
    • PIT-1
    • BRN-3: A
    • B
    • C
    • Octamer transcription factor: 1
    • 2
    • 3/4
    • 6
    • 7
    • 11
  • SATB2
  • ZEB
    • 1
    • 2
(3.2) Paired box
  • PAX
    • 1
    • 2
    • 3
    • 4
    • 5
    • 6
    • 7
    • 8
    • 9
  • PRRX
    • 1
    • 2
  • PROP1
  • PHOX
    • 2A
    • 2B
  • RAX
  • SHOX
  • SHOX2
  • VSX1
  • VSX2
  • Bicoid
    • GSC
    • BICD2
    • OTX
      • 1
      • 2
    • PITX
      • 1
      • 2
      • 3
(3.3) Fork head / winged helix
  • E2F
    • 1
    • 2
    • 3
    • 4
    • 5
  • FOX proteins
    • A1
    • A2
    • A3
    • B1
    • B2
    • C1
    • C2
    • D1
    • D2
    • D3
    • D4
    • D4L1
    • D4L3
    • D4L4
    • D4L5
    • D4L6
    • E1
    • E3
    • F1
    • F2
    • G1
    • H1
    • I1
    • I2
    • I3
    • J1
    • J2
    • J3
    • K1
    • K2
    • L1
    • L2
    • M1
    • N1
    • N2
    • N3
    • N4
    • O1
    • O3
    • O4
    • O6
    • P1
    • P2
    • P3
    • P4
    • Q1
    • R1
    • R2
    • S1
(3.4) Heat shock factors
  • HSF
    • 1
    • 2
    • 4
(3.5) Tryptophan clusters
  • ELF
    • 2
    • 4
    • 5
  • EHF
  • ELK
    • 1
    • 3
    • 4
  • ERF
  • ETS
    • 1
    • 2
    • ERG
    • SPIB
  • ETV
    • 1
    • 4
    • 5
    • 6
  • FLI1
  • Interferon regulatory factors
    • 1
    • 2
    • 3
    • 4
    • 5
    • 6
    • 7
    • 8
  • MYB
  • MYBL2
(3.6) TEA domain
  • transcriptional enhancer factor
    • 1
    • 2
    • 3
    • 4
(4) β-Scaffold factors with minor groove contacts
(4.1) Rel homology region
  • NF-κB
    • NFKB1
    • NFKB2
    • REL
    • RELA
    • RELB
  • NFAT
    • C1
    • C2
    • C3
    • C4
    • 5
(4.2) STAT
  • STAT
    • 1
    • 2
    • 3
    • 4
    • 5
    • 6
(4.3) p53-like
  • p53 p63 p73 family
    • p53
    • TP63
    • p73
  • TBX
    • 1
    • 2
    • 3
    • 5
    • 19
    • 21
    • 22
    • TBR1
    • TBR2
    • TFT
  • MYRF
(4.4) MADS box
  • Mef2
    • A
    • B
    • C
    • D
  • SRF
(4.6) TATA-binding proteins
  • TBP
  • TBPL1
(4.7) High-mobility group
  • BBX
  • HMGB
    • 1
    • 2
    • 3
    • 4
  • HMGN
    • 1
    • 2
    • 3
    • 4
  • HNF
    • 1A
    • 1B
  • SOX
    • 1
    • 2
    • 3
    • 4
    • 5
    • 6
    • 8
    • 9
    • 10
    • 11
    • 12
    • 13
    • 14
    • 15
    • 17
    • 18
    • 21
  • SRY
  • SSRP1
  • TCF/LEF
    • TCF
      • 1
      • 3
      • 4
    • LEF1
  • TOX
    • 1
    • 2
    • 3
    • 4
(4.9) Grainyhead
  • TFCP2
(4.10) Cold-shock domain
  • CSDA
  • YBX1
(4.11) Runt
  • CBF
    • CBFA2T2
    • CBFA2T3
    • RUNX1
    • RUNX2
    • RUNX3
    • RUNX1T1
(0) Other transcription factors
(0.2) HMGI(Y)
  • HMGA
    • 1
    • 2
  • HBP1
(0.3) Pocket domain
  • Rb
  • RBL1
  • RBL2
(0.5) AP-2/EREBP-related factors
  • Apetala 2
  • EREBP
  • B3
(0.6) Miscellaneous
  • ARID
    • 1A
    • 1B
    • 2
    • 3A
    • 3B
    • 4A
  • CAP
  • IFI
    • 16
    • 35
  • MLL
    • 2
    • 3
    • T1
  • MNDA
  • NFY
    • A
    • B
    • C
  • Rho/Sigma
see also transcription factor/coregulator deficiencies
  • v
  • t
  • e
TGFβ receptor superfamily modulators
Type I
ALK1 (ACVRL1)
  • Agonists: Activin (A, B, AB)
  • Avotermin
  • BMP (10)
  • Cetermin
  • GDF (2 (BMP9))
  • TGFβ (1, 2, 3)
  • Antibodies: Ascrinvacumab
  • Kinase inhibitors: K-02288
  • ML-347 (LDN-193719, VU0469381)
  • Decoy receptors: Dalantercept
  • Other inhibitors: Disitertide
ALK2 (ACVR1A)
  • Agonists: Activin (A, B, AB)
  • AMH (MIS)
  • Avotermin
  • BMP (5, 6, 7, 8A, 8B)
  • Eptotermin alfa
  • TGFβ (1, 2, 3)
  • Kinase inhibitors: DMH-1
  • DMH-2
  • Dorsomorphin (BML-275)
  • K-02288
  • ML-347 (LDN-193719, VU0469381)
ALK3 (BMPR1A)
  • Agonists: AMH (MIS)
  • BMP (2, 4, 5, 6, 7, 8A, 8B)
  • Dibotermin alfa
  • Eptotermin alfa
  • Kinase inhibitors: DMH-2
  • Dorsomorphin (BML-275)
  • K-02288
ALK4 (ACVR1B)
  • Agonists: Activin (A, B, AB)
  • GDF (1, 3, 11 (BMP11))
  • Myostatin (GDF8)
  • Nodal
  • Antagonists: Inhibin (A, B)
  • Lefty (1, 2)
  • Kinase inhibitors: A 83-01
  • SB-431542
  • SB-505124
ALK5 (TGFβR1)
  • Agonists: Avotermin
  • GDF (10 (BMP3B), 11 (BMP11))
  • TGFβ (1, 2, 3)
  • Antibodies: Fresolimumab
  • Lerdelimumab
  • Metelimumab
  • Kinase inhibitors: A 83-01
  • D-4476
  • GW-788388
  • LY-364947
  • LY-2109761
  • Galunisertib (LY-2157299)
  • R-268712
  • RepSox (E-616452, SJN-2511)
  • SB-431542
  • SB-505124
  • SB-525334
  • SD-208
ALK6 (BMPR1B)
  • Agonists: BMP (2, 4, 5, 6, 7, 8A, 8B, 15 (GDF9B))
  • Dibotermin alfa
  • Eptotermin alfa
  • GDF (5 (BMP14), 6 (BMP13), 7 (BMP12), 9, 15)
  • Radotermin
  • Kinase inhibitors: DMH-2
  • Dorsomorphin (BML-275)
  • K-02288
ALK7 (ACVR1C)
  • Agonists: GDF (1, 3, 11 (BMP11))
  • Nodal
  • Antagonists: Lefty (1, 2)
  • Kinase inhibitors: A 83-01
  • SB-431542
  • SB-505124
Type II
TGFβR2
  • Agonists: Avotermin
  • GDF (10 (BMP3B))
  • TGFβ (1, 2, 3)
  • Antibodies: Fresolimumab
  • Lerdelimumab
  • Metelimumab
  • Kinase inhibitors: DMH-2
  • LY-364947
BMPR2
  • Agonists: BMP (2, 4, 6, 7, 10)
  • Dibotermin alfa
  • Eptotermin alfa
  • GDF (2 (BMP9), 5 (BMP14), 6 (BMP13), 7 (BMP12))
  • Radotermin
  • Antagonists: Inhibin (A, B)
ACVR2A (ACVR2)
  • Agonists: Activin (A, B, AB)
  • BMP (2, 4, 5, 6, 7, 8A, 8B, 15 (GDF9B))
  • Dibotermin alfa
  • Eptotermin alfa
  • GDF (1, 3, 5 (BMP14), 6 (BMP13), 7 (BMP12), 9, 11 (BMP11), 15)
  • Myostatin (GDF8)
  • Nodal
  • Radotermin
  • Antagonists: Inhibin (A, B)
  • Lefty (1, 2)
  • Decoy receptors: Sotatercept
ACVR2B
  • Agonists: Activin (A, B, AB)
  • BMP (2, 4, 6, 7)
  • Dibotermin alfa
  • Eptotermin alfa
  • GDF (1, 3, 5 (BMP14), 6 (BMP13), 7 (BMP12))
  • Myostatin (GDF8)
  • Nodal
  • Osteogenin (BMP3, BMP3A)
  • Radotermin
  • Antagonists: Inhibin (A, B)
  • Lefty (1, 2)
  • Decoy receptors: Ramatercept
AMHR2 (AMHR)
  • Agonists: AMH (MIS)
Type III
TGFβR3 (β-glycan)
  • Ligands: Avotermin
  • Inhibin (A, B)
  • TGFβ (1, 2, 3)
Unsorted
  • Endogenous antagonists/inhibitors: BAMBI
  • Cerberus (CER1)
  • Chordin
  • DAN (PARN)
  • Decorin
  • Follistatin
  • Gremlin (Drm)
  • LTBP1
  • Noggin
  • TGIF
  • Thrombospondin 1 (THBS1)
  • Tomoregulin 1
  • Antibodies: Stamulumab (against myostatin)
  • TRC105 (against endoglin)
  • Others: Endoglin


Stub icon

This cell biology article is a stub. You can help Wikipedia by adding missing information.

  • v
  • t
  • e
Retrieved from "https://en.wikipedia.org/w/index.php?title=SMAD9&oldid=1327928640"
Categories:
  • Genes on human chromosome 13
  • Developmental genes and proteins
  • MH1 domain
  • MH2 domain
  • R-SMAD
  • Transcription factors
  • Human proteins
  • Cell biology stubs
Hidden categories:
  • Articles with short description
  • Short description matches Wikidata
  • All stub articles

  • indonesia
  • Polski
  • العربية
  • Deutsch
  • English
  • Español
  • Français
  • Italiano
  • مصرى
  • Nederlands
  • 日本語
  • Português
  • Sinugboanong Binisaya
  • Svenska
  • Українська
  • Tiếng Việt
  • Winaray
  • 中文
  • Русский
Sunting pranala
url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url
Pusat Layanan

UNIVERSITAS TEKNOKRAT INDONESIA | ASEAN's Best Private University
Jl. ZA. Pagar Alam No.9 -11, Labuhan Ratu, Kec. Kedaton, Kota Bandar Lampung, Lampung 35132
Phone: (0721) 702022
Email: pmb@teknokrat.ac.id